ORIGINAL ARTICLE |
|
Year : 2014 | Volume
: 20
| Issue : 2 | Page : 153-154 |
|
Cost-effectiveness analysis for triple markers serum screening for Down's syndrome in Thai setting
Viroj Wiwanitkit
Hainan Medical University, China; Faculty of Medicine, University of Nis, Serbia; Joseph Ayobabalola University, Nigeria,
Correspondence Address:
Viroj Wiwanitkit Wiwanitkit House, Bangkhae, Bangkok 10160, Thailand
![Login to access the Email id](http://www.medknow.com/images/email.gif) Source of Support: None, Conflict of Interest: None
DOI: 10.4103/0971-6866.142880
|
|
Background: Down's syndrome is an important congenital chromosomal disorder that can be seen around the world. The antenatal screening for this disorder is an important processing in present obstetrics.
Objective: Due to the concept of first do no harm, the use of noninvasive test is recommended. The triple marker screening test has been introduced for a few years and acceptable for its effi cacy.
Result: However, an important concern is on its cost-effectiveness. Here, the author analyze and present the cost-effectiveness of the triple markers serum screening for Down's syndrome in Thai setting.
Conclusion: According to this work, the cost per effectiveness of triple markers serum screening is slightly lower than standard amniocentesis test. |
|
|
|
[FULL TEXT] [PDF]* |
|
![Email this article](/ServeContent?url=http%3A%2F%2Fwww.ijhg.com%2Ftemplates%2Ficon_mail.gif) |
|